The findings of this study suggest that PLE0 exhibits a promising anti-metastatic capacity by targeting JNK as a key factor associated with invasion, migration, matrix degradation, and EMT by inhibiting MMP-2/9 in CRC cells. The gene discussed is MMP2; the disease is colorectal carcinoma.